Viral Vaccines

Our Viral Vaccine Program seeks to pair our experience in protein and nucleic acid characterization with advances in cell culture technologies to provide a comprehensive and integrated testing and control program for viral vaccine development.

Our experience spans the range of vaccine products:

• Live attenuated preparation of bacteria, viruses or parasites
• Inactivated (killed) whole organisms
• Living irradiated cells
• Crude fractions or purified immunogens, including those derived from recombinant DNA in a host cell
• Conjugates formed by covalent linkage of components
• Synthetic antigens
• Polynucleotides - such as the plasmid DNA vaccines
• Living vectored cells expressing specific heterologous immunogens
• Cells pulsed with immunogen

Included in our Viral Vaccine Program are validated assays to meet your testing needs at every point in the development and manufacturing process:

• Raw Material Testing
• Cell Line Development
• Cell Banking Services
• Cell Storage Services
• Cell Line Characterization
• Release Testing (Unprocessed Bulk and Purified Product)
• Process Validation
• Protein Characterization
• Stability Studies

US Sample Submission Forms

What's New

All news items

 Charles River Home | Careers | Humane Care | Events | News Room | Investor Relations | Site Index | Contact